Somavert20mgpolvoydisolventeparasolucióninyectable

Somavert20mgpolvoydisolventeparasolucióninyectable Uses, Dosage, Side Effects, Food Interaction and all others data.

Somavert20mgpolvoydisolventeparasolucióninyectable is a highly selective growth hormone (GH) receptor antagonist. It is used to treat acromegaly. Unlike dopamine or somatostatin analogs (which inhibit growth hormone secretion), this drug actually blocks the hepatic (GH-mediated) production of insulin like growth factor (IGF-1), which is the main mediator of growth hormone activity.

Somavert is used for the treatment of acromegaly, which arises from excessive IGF-1 levels. Somavert selectively binds to growth hormone (GH) receptors on cell surfaces, where it blocks the binding of endogenous GH, and thus interferes with GH signal transduction. Inhibition of GH action results in decreased serum concentrations of insulin-like growth factor-I (IGF-I), and IGF binding protein-3 (IGFBP-3). This reduces the symptoms of acromegaly.

Trade Name Somavert20mgpolvoydisolventeparasolucióninyectable
Availability Prescription only
Generic Pegvisomant
Pegvisomant Other Names Pegvisomant
Related Drugs octreotide, bromocriptine, Sandostatin, lanreotide, Somatuline Depot, Parlodel
Type
Formula C990H1532N262O300S7
Weight 22129.0 Da
Groups Approved
Therapeutic Class
Manufacturer
Available Country Spain
Last Updated: September 19, 2023 at 7:00 am
Somavert20mgpolvoydisolventeparasolucióninyectable
Somavert20mgpolvoydisolventeparasolucióninyectable

Uses

Somavert20mgpolvoydisolventeparasolucióninyectable is a growth hormone receptor antagonist used to treat acromegaly.

Somavert20mgpolvoydisolventeparasolucióninyectable is a growth hormone receptor antagonist used for the treatment of acromegaly.

Somavert20mgpolvoydisolventeparasolucióninyectable is also used to associated treatment for these conditions: Acromegaly

How Somavert20mgpolvoydisolventeparasolucióninyectable works

Somavert selectively binds to growth hormone (GH) receptors on cell surfaces, where it blocks the binding of endogenous GH. This leads to the normalization of serum IGF-1 levels.

Food Interaction

No interactions found.

Somavert20mgpolvoydisolventeparasolucióninyectable Disease Interaction

Moderate: diabetes, liver dysfunction

Volume of Distribution

  • 7 L

Half Life

~6 days

Clearance

  • 36 - 28 mL/h [SC doses ranging from 10 to 20 mg/day]

Innovators Monograph

You find simplified version here Somavert20mgpolvoydisolventeparasolucióninyectable

*** Taking medicines without doctor's advice can cause long-term problems.
Share